StemCells, Inc. is a public biopharmaceutical company headquartered in Newark
, California, that is developing purified human neural stem cells (HuCNS-SCs) ...
Researches, develops, and markets cell-based therapies. Includes, with details
of clinical trials information for investors, and profile of company in Palo Alto, ...
StemCells, Inc. Groundbreaking science. Breakthrough medicine. ... Home ·
Legal Notices · Careers · Site Map. © 2000 - 2017 StemCells, Inc. All Rights
StemCells, Inc. is poised to be among the first to market stem cell-based
therapeutic products to treat diseases and disorders of the central nervous
StemCells, Inc. :STEM-US: Earnings Analysis: Q3, 2016 By the Numbers ...
Categories: Yahoo Finance Get free summary analysis StemCells, Inc. reports ...
StemCells, Inc. is currently engaged in clinical development of its proprietary
HuCNS-SC<sup>®</sup> (purified human neural stem cells) platform technology to treat ...
Jun 1, 2016 ... StemCells Inc., once a darling of investors, will shutter after failing to advance
stem cell treatments for Alzheimer's, vision loss and spinal cord ...
Real-time trade and investing ideas on StemCells Inc. ($STEM) from the largest
community of traders and investors.
STEMCELL Technologies develops cell culture media, cell separation systems,
instruments and other reagents for use in life sciences research.
Aug 16, 2016 ... NEWARK, Calif. and YOKNEAM, Israel, Aug. 16, 2016 (GLOBE NEWSWIRE) --
StemCells, Inc. (NASDAQ:STEM) and Microbot Medical Ltd., ...